Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Active, Not Recruiting

Combination Immunotherapy in Rare Cancers Under InvesTigation

NCT04969887

Conditions
Advanced Biliary Tract Cancer, Female Reproductive System Neoplasm, Female Urogenital Diseases, +14 more
Locations
  • Border Medical Oncology Unit Albury, New South Wales, Australia
  • Orange Health Service Orange, New South Wales, Australia
  • Blacktown Hospital Sydney, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

NCT04471727

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +26 more
Locations
  • Cedar-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Post-Authorization Long-Term Safety Study of LUTATHERA

NCT03691064

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Banner MD Anderson Cancer Center Phoenix, Arizona, United States
  • The Ohio State University Wexner Medical Center Portland, Ohio, United States
  • Oregon Health & Sciences University Hospital Portland, Oregon, United States
  • Virginia Mason in Seattle Seattle, Washington, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

NCT03600233

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +21 more
Locations
  • Chang Gung Memorial Hospital, KaoHsiung Kaohsiung City, Taiwan
  • Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
  • New Taipei Municipal TuCheng Hospital New Taipei City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details
Active, Not Recruiting

Neuroendocrine Tumors - Patient Reported Outcomes

NCT05064150

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of Kansas Medical Center Research Institute, Inc Kansas City, Kansas, United States
  • Regents of the University of Michigan Ann Arbor, Michigan, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors

NCT02743741

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • London Health Sciences Centre London, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Sunnybrook Odette Cancer Center Toronto, Ontario, Canada
View Trial Details

Related conditions